Abstract

Losartan Potassium 2.5-mg/mL Oral Liquid

Author(s): Allen Loyd V Jr

Issue: Jul/Aug 2023 - Volume 27, Number 4

Page(s): 326

Download in electronic PDF format for $75
  • Losartan Potassium 2.5-mg/mL Oral Liquid Page 1

Abstract

A formulation for preparing Losartan Potassium 2.5-mg/mL Oral Liquid. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords

  • losartan potassium
  • formulation
  • hypertension
  • high blood pressure
  • antihypertensive agent
  • angiotensin II receptor blocker
  • ARB

Related Categories

  • FORMULATIONS
  • CARDIOLOGY
  • DOSAGE FORMS/DRUG CARRIERS

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
May/Jun 2007
Pg. 248
Losartan Potassium 2.5-mg/mL Oral Liquid
Author(s): Allen Loyd V Jr
Jul/Aug 2023
Pg. 326
Losartan Potassium 2.5-mg/mL Oral Liquid
Author(s): Allen Loyd V Jr
May/Jun 2004
Pg. 181-185
Compounding in the Pharmacy Curriculum: Beyond the Basics
Author(s): Hinkle Amanda R, Newton Gail D
Nov/Dec 2004
Pg. 462-465
Basics of Compounding for Cough
Author(s): Allen Loyd V Jr
Jul/Aug 2001
Pg. 310-312
Wetting and/or Solubilizing Agents, Featured Excipient:
Author(s): Allen Loyd V Jr
May/Jun 2017
Pg. 232
Candesartan Cilexetil 0.1-mg/mL to 2.0-mg/mL Oral Suspension
Author(s): Allen Loyd V Jr
Jan/Feb 2003
Pg. 61
Potassium Iodide 130-mg Capsules and Potassium Iodide 16-mg/mL Oral Liquid
Author(s): Allen Loyd V Jr
Jan/Feb 2014
Pg. 67
Potassium Chloride 2-mEq/mL Injection
Author(s): Allen Loyd V Jr
May/Jun 2008
Pg. 269
Valsartan 4-mg/mL Oral Liquid
Author(s): Allen Loyd V Jr
Jul/Aug 2001
Pg. 323-324
Compatibility and Stability of Potassium Chloride and Magnesium Sulfate in 0.9% Sodium Chloride Injection and 5% Dextrose Injection Solutions
Author(s): Quay Irene, Tan Edward
Sep/Oct 2019
Pg. 412
Valsartan 4 mg/mL in Vehicle for Oral Solution USP
Author(s): Allen Loyd V Jr
Mar/Apr 2013
Pg. 153
Verapamil Hydrochloride 2.5-mg/mL Injection
Author(s): Allen Loyd V Jr
Mar/Apr 2017
Pg. 147
Candesartan Cilexetil 8 mg Liquid-Filled Capsules
Author(s): Allen Loyd V Jr
Mar/Apr 2018
Pg. 152
Spironolactone 5-mg/mL in Suspendit Oral Suspension
Author(s): Allen Loyd V Jr
Sep/Oct 2006
Pg. 386
Lisinopril 1-mg/mL, Sodium Citrate, and Citric Acid Oral Liquid
Author(s): Allen Loyd V Jr
Sep/Oct 1999
Pg. 415-420
Physical Compatibility of Calcium Acetate and Potassium Phosphates in Parenteral Nutrition Solutions Containing Aminosyn II
Author(s): Zhang Yanping, Xu Quanyun, Trissel Lawrence A, Baker Mary B
May/Jun 2019
Pg. 237
Valsartan 16-mg/mL Oral Suspension
Author(s): Allen Loyd V Jr
Sep/Oct 2021
Pg. 421
Spironolactone 2-mg/mL or 2-5.mg/mL in SyrSpend SF pH4
Author(s): Allen Loyd V Jr
May/Jun 2022
Pg. 234
Candesartan Cilexitil 1 mg/mL Syrup
Author(s): Allen Loyd V Jr
Sep/Oct 2016
Pg. 438-439
A Simplified Extemporaneously Prepared Potassium Chloride Oral Solution
Author(s): Tannous Elias, Tal Yana, Amarny Kamal